These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 28971874)
21. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors. Salahuddin P; Kumar A; Khan AU Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223 [TBL] [Abstract][Full Text] [Related]
22. Active-Site Plasticity Is Essential to Carbapenem Hydrolysis by OXA-58 Class D β-Lactamase of Acinetobacter baumannii. Pratap S; Katiki M; Gill P; Kumar P; Golemi-Kotra D Antimicrob Agents Chemother; 2016 Jan; 60(1):75-86. PubMed ID: 26459904 [TBL] [Abstract][Full Text] [Related]
23. Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics. Sun Z; Hu L; Sankaran B; Prasad BVV; Palzkill T Nat Commun; 2018 Oct; 9(1):4524. PubMed ID: 30375382 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate. Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325 [TBL] [Abstract][Full Text] [Related]
25. Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae. Watkins RR; Deresinski S Expert Rev Anti Infect Ther; 2017 Oct; 15(10):893-895. PubMed ID: 28914107 [No Abstract] [Full Text] [Related]
26. Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48. Lahiri SD; Mangani S; Jahić H; Benvenuti M; Durand-Reville TF; De Luca F; Ehmann DE; Rossolini GM; Alm RA; Docquier JD ACS Chem Biol; 2015 Feb; 10(2):591-600. PubMed ID: 25406838 [TBL] [Abstract][Full Text] [Related]
27. Targeting metallo-β-lactamase enzymes in antibiotic resistance. King DT; Strynadka NC Future Med Chem; 2013 Jul; 5(11):1243-63. PubMed ID: 23859206 [TBL] [Abstract][Full Text] [Related]
28. Genetic and Biochemical Characterization of FRI-1, a Carbapenem-Hydrolyzing Class A β-Lactamase from Enterobacter cloacae. Dortet L; Poirel L; Abbas S; Oueslati S; Nordmann P Antimicrob Agents Chemother; 2015 Dec; 59(12):7420-5. PubMed ID: 26392482 [TBL] [Abstract][Full Text] [Related]
29. Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation. Saral A; Leonard DA; Duzgun AO; Cicek AC; June CM; Sandalli C J Antibiot (Tokyo); 2016 Dec; 69(12):858-862. PubMed ID: 27168312 [TBL] [Abstract][Full Text] [Related]
30. Using steric hindrance to design new inhibitors of class C beta-lactamases. Trehan I; Morandi F; Blaszczak LC; Shoichet BK Chem Biol; 2002 Sep; 9(9):971-80. PubMed ID: 12323371 [TBL] [Abstract][Full Text] [Related]
31. Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam. Pemberton OA; Noor RE; Kumar M V V; Sanishvili R; Kemp MT; Kearns FL; Woodcock HL; Gelis I; Chen Y Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5818-5825. PubMed ID: 32123084 [TBL] [Abstract][Full Text] [Related]
32. Discovery of 2-Sulfinyl-Diazabicyclooctane Derivatives, Potential Oral β-Lactamase Inhibitors for Infections Caused by Serine β-Lactamase-Producing Enterobacterales. Fujiu M; Yokoo K; Sato J; Shibuya S; Komano K; Kusano H; Sato S; Aoki T; Kohira N; Kanazawa S; Watari R; Kawachi T; Hirakawa Y; Nagamatsu D; Kashiwagi E; Maki H; Yamawaki K J Med Chem; 2021 Jul; 64(13):9496-9512. PubMed ID: 34143627 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1. Nukaga M; Bethel CR; Thomson JM; Hujer AM; Distler A; Anderson VE; Knox JR; Bonomo RA J Am Chem Soc; 2008 Sep; 130(38):12656-62. PubMed ID: 18761444 [TBL] [Abstract][Full Text] [Related]
34. Routes of Synthesis of Carbapenems for Optimizing Both the Inactivation of L,D-Transpeptidase LdtMt1 of Mycobacterium tuberculosis and the Stability toward Hydrolysis by β-Lactamase BlaC. Iannazzo L; Soroka D; Triboulet S; Fonvielle M; Compain F; Dubée V; Mainardi JL; Hugonnet JE; Braud E; Arthur M; Etheve-Quelquejeu M J Med Chem; 2016 Apr; 59(7):3427-38. PubMed ID: 26937999 [TBL] [Abstract][Full Text] [Related]
35. Discovery of Davies DT; Leiris S; Zalacain M; Sprynski N; Castandet J; Bousquet J; Lozano C; Llanos A; Alibaud L; Vasa S; Pattipati R; Valige R; Kummari B; Pothukanuri S; De Piano C; Morrissey I; Holden K; Warn P; Marcoccia F; Benvenuti M; Pozzi C; Tassone G; Mangani S; Docquier JD; Pallin D; Elliot R; Lemonnier M; Everett M J Med Chem; 2020 Dec; 63(24):15802-15820. PubMed ID: 33306385 [TBL] [Abstract][Full Text] [Related]
36. Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases. Hecker SJ; Reddy KR; Totrov M; Hirst GC; Lomovskaya O; Griffith DC; King P; Tsivkovski R; Sun D; Sabet M; Tarazi Z; Clifton MC; Atkins K; Raymond A; Potts KT; Abendroth J; Boyer SH; Loutit JS; Morgan EE; Durso S; Dudley MN J Med Chem; 2015 May; 58(9):3682-92. PubMed ID: 25782055 [TBL] [Abstract][Full Text] [Related]
37. The rapid spread of carbapenem-resistant Enterobacteriaceae. Potter RF; D'Souza AW; Dantas G Drug Resist Updat; 2016 Nov; 29():30-46. PubMed ID: 27912842 [TBL] [Abstract][Full Text] [Related]
38. Crystal structures of the Bacillus licheniformis BS3 class A beta-lactamase and of the acyl-enzyme adduct formed with cefoxitin. Fonzé E; Vanhove M; Dive G; Sauvage E; Frère JM; Charlier P Biochemistry; 2002 Feb; 41(6):1877-85. PubMed ID: 11827533 [TBL] [Abstract][Full Text] [Related]
39. Crystal Structure of the Metallo-β-Lactamase GOB in the Periplasmic Dizinc Form Reveals an Unusual Metal Site. Morán-Barrio J; Lisa MN; Larrieux N; Drusin SI; Viale AM; Moreno DM; Buschiazzo A; Vila AJ Antimicrob Agents Chemother; 2016 Oct; 60(10):6013-22. PubMed ID: 27458232 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design. Drawz SM; Babic M; Bethel CR; Taracila M; Distler AM; Ori C; Caselli E; Prati F; Bonomo RA Biochemistry; 2010 Jan; 49(2):329-40. PubMed ID: 19925018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]